Synthesis of Polycyclic Hetero-Fused 7-Deazapurine Heterocycles and Nucleosides through C-H Dibenzothiophenation and Negishi Coupling

J Am Chem Soc. 2022 Oct 26;144(42):19437-19446. doi: 10.1021/jacs.2c07517. Epub 2022 Oct 16.

Abstract

A new approach for synthesizing polycyclic heterofused 7-deazapurine heterocycles and the corresponding nucleosides was developed based on C-H functionalization of diverse (hetero)aromatics with dibenzothiophene-S-oxide followed by the Negishi cross-cooupling with bis(4,6-dichloropyrimidin-5-yl)zinc. This cross-coupling afforded a series of (het)aryl-pyrimidines that were converted to fused deazapurine heterocycles through azidation and thermal cyclization. The fused heterocycles were glycosylated to the corresponding 2'-deoxy- and ribonucleosides, and a series of derivatives were prepared by nucleophilic substitutions at position 4. Four series of new polycyclic thieno-fused 7-deazapurine nucleosides were synthesized using this strategy. Most of the deoxyribonucleosides showed good cytotoxic activity, especially for the CCRF-CEM cell line. Phenyl- and thienyl-substituted thieno-fused 7-deazapurine nucleosides were fluorescent, and the former one was converted to 2'-deoxyribonucleoside triphosphate for enzymatic synthesis of labeled oligonucleotides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Deoxyribonucleosides
  • Nucleosides*
  • Oligonucleotides
  • Oxides
  • Purine Nucleosides
  • Pyrimidines
  • Ribonucleosides*
  • Zinc

Substances

  • 7-deazapurine
  • Nucleosides
  • Ribonucleosides
  • Pyrimidines
  • Oxides
  • Zinc
  • Oligonucleotides
  • Deoxyribonucleosides
  • Purine Nucleosides